New treatment pathway for hyperaldosteronism identified

08 Dec 2017


According to a study, published in JCI Insight, an underlying mechanism that causes hyperaldosteronism has been identified, and offers new targets for its treatment, as well as addressing secondary hypertension.

Newswise


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story